Under the terms of the agreement, Kyorin will receive $55m upfront and will be eligible for milestone payments of up to ...

In this article, we will look at the 11 Best Undervalued Stocks to Invest in Now.

Let's continue. An additional factor that, in my opinion, makes Novartis an attractive stock for long-term investors is its acquisition of Anthos Therapeutics for up to $3.1 billion. I believe ...

Also Read: Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal For over 30 years, Congress has imposed price ceilings on prescription drugs ...

On February 11, 2025, NVS entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage Biopharmaceutical Company. NVS will also acquire Anthos’ ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...